Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.

Alterations in glycosphingolipid (GSL) production results in lysosomal storage disorders associated with neurodegenerative changes. In Gaucher's disease, the patients also develop osteoporosis that is ameliorated upon treatment for the underlying defect in GSL metabolism. The role of GSLs in os...

Full description

Bibliographic Details
Main Authors:	Ersek, A, Karadimitris, A, Horwood, N
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Effect of Glycosphingolipids on Osteoclastogenesis and Osteolytic Bone Diseases
by: Adel eErsek, et al.
Published: (2012-08-01)

Melatonin Inhibits Osteoclastogenesis and Osteolytic Bone Metastasis: Implications for Osteoporosis
by: Iona J. MacDonald, et al.
Published: (2021-08-01)

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease
by: Ersek, A, et al.
Published: (2015)

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease
by: Leng, H, et al.
Published: (2022)

Reduced bone density in XLA patients, an effect of B cell deficiency on osteoclast differentiation and osteolytic activity
by: Danks, L, et al.
Published: (2008)

Reduced bone density in XLA patients, an effect of b-cell deficiency on osteoclast differentiation and osteolytic activity
by: Danks, L, et al.
Published: (2008)

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease
by: Houfu Leng, et al.
Published: (2022-12-01)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
by: Croucher, P, et al.
Published: (2001)

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids
by: Xu, K, et al.
Published: (2009)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
by: Croucher, P, et al.
Published: (2001)

Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis.
by: Vattakuzhi, Y, et al.
Published: (2012)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
by: Huan Liu, et al.
Published: (2022-06-01)

Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease
by: Iva R. Nedeva, et al.
Published: (2021-04-01)

Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
by: Salvatore J. Coniglio
Published: (2018-06-01)

An Atypical Case of POEMS Syndrome with an Osteolytic Bone Lesion
by: Kumar Rahul, et al.
Published: (2015-06-01)

Bisphosphonate treatment of benign multifocal and unifocal osteolytic tumours of bone.
by: Gibbons, C, et al.
Published: (2003)

T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
by: Mirosavljevic, D, et al.
Published: (2003)

Promotion of bone morphogenetic protein signaling by tetraspanins and glycosphingolipids.
by: Zhiyu Liu, et al.
Published: (2015-05-01)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
by: Dongzheng Gai, et al.
Published: (2022-09-01)

Osteolytic lesions in myelofibrosis
by: Isla Johnson, et al.
Published: (2021-07-01)

Lipidomics of Glycosphingolipids
by: Hany Farwanah, et al.
Published: (2012-02-01)

Dkk1 modulates osteoclastogenesis and bone resorption: Implications for myeloma bone disease.
by: Oyajobi, B, et al.
Published: (2005)

Introduction: Glycosphingolipids in cell biology and disease.
by: Sillence, D, et al.
Published: (2004)

Osteolytic potential of triphenyl bismuth as an alternative contrast medium in acrylic bone cement.
by: Xu, H, et al.
Published: (2005)

The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models
by: Marta Martín-Fernández, et al.
Published: (2017-04-01)

Therapeutic potential of a prominent dihydroxyflavanone pinocembrin for osteolytic bone disease: In vitro and in vivo evidence
by: Guoju Hong, et al.
Published: (2024-03-01)

Multifocal Osteolytic tuberculosis - Uncommon presentation of common disease
by: Majed B Momin1 , Sandeep S2 , Anamika Aluri3 , Akhhil M4
Published: (2018-08-01)

Multiple roles of angiopoietin-like 4 in osteolytic disease
by: Knowles, H
Published: (2017)

The Effect of Xylitol on Osteoclastogenesis in Experimentally Induced Bone Defect in Rabbits
by: Ahmed H. Naji, et al.
Published: (2022-01-01)

Glycosphingolipid disorders of the brain.
by: Boomkamp, S, et al.
Published: (2008)

Glycosphingolipids in human parasites
by: Richard D. Cummings
Published: (2023-09-01)

JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
by: Mariely A. Godoi, et al.
Published: (2023-06-01)

New developments in treating glycosphingolipid storage diseases.
by: Platt, F, et al.
Published: (2005)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
by: Jeyakumar, M, et al.
Published: (2002)

The Function and Mechanism of Anti-Inflammatory Factor Metrnl Prevents the Progression of Inflammatory-Mediated Pathological Bone Osteolytic Diseases
by: Liu N, et al.
Published: (2024-03-01)

Multiple osteolytic primary peripheral T-cell bone lymphoma: the first case report
by: Chen Li, et al.
Published: (2021-10-01)

Imaging Findings of Various Calvarial Bone Lesions with a Focus on Osteolytic Lesions
by: Younghee Yim, et al.
Published: (2016-01-01)

The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis.
by: Chiara Secondini, et al.
Published: (2011-01-01)

A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo
by: Lwin, S, et al.
Published: (2017)

A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
by: Aristea-Maria Papanota, et al.
Published: (2021-07-01)